
Dolma Impact Fund, the first international private equity firm focused on Nepal, made a first close of its second fund earlier this year.
Dolma Impact Fund, the first international private equity firm focused on Nepal, made a first close of its second fund earlier this year.
Dr. Krishna Maharjan studies chromosomes and cell structures. One of Nepal’s leading cytogeneticists, he broadened my understanding of how artificial intelligence is transforming health care...